Showing results (591-600 of 919) with videos related to

Sort By:
Pageof 92
Expert Review of Molecular Diagnostics|October 15, 2019
Liquid biopsy in the clinical management of bladder cancer: current status and future developmentsErik Kouba, Antonio Lopez-Beltran, Rodolfo Montironi, et al.
Current Drug Metabolism|May 20, 2017
Circulating Tumor Cells: A Reliable Biomarker for Prostate Cancer Treatment Assessment?Chiara Ciccarese, Rodolfo Montironi, Michelangelo Fiorentino, et al.
Cancer Treatment Reviews|March 15, 2016
Metabolic phenotype of bladder cancerFrancesco Massari, Chiara Ciccarese, Matteo Santoni, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 15, 2008
Hypermethylation of tumor-suppressor gene CpG islands in small-cell carcinoma of the urinary bladderPhillip H Abbosh, Mingsheng Wang, John N Eble, et al.
The American Journal of Surgical Pathology|February 9, 2010
Urothelial carcinoma of the bladder, lipid cell variant: clinicopathologic findings and LOH analysisAntonio Lopez-Beltran, Mahul B Amin, Pedro S Oliveira, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2007
Epidermal growth factor receptor protein expression and gene amplification in small cell carcinoma of the urinary bladderXiaoyan Wang, Shaobo Zhang, Gregory T MacLennan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 30, 2010
Multilocular cystic renal cell carcinoma is a subtype of clear cell renal cell carcinomaShams Halat, John N Eble, David J Grignon, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|April 13, 2007
Chromatin phenotype karyometry can predict recurrence in papillary urothelial neoplasms of low malignant potentialRodolfo Montironi, Marina Scarpelli, Antonio Lopez-Beltran, et al.
Current Drug Metabolism|October 16, 2015
Metabolic Alterations in Renal and Prostate CancerChiara Ciccarese, Matteo Santoni, Francesco Massari, et al.
Expert Review of Anticancer Therapy|August 8, 2020
Combination therapy in advanced urothelial cancer: the role of PARP, HER-2 and mTOR inhibitorsVeronica Mollica, Ilaria Maggio, Antonio Lopez-Beltran, et al.
Pageof 92